He is the director of the telemedicine screening program for ROP at Vanderbilt University Medical Center. He is a former executive committee member of the Pediatric Eye Disease Investigator Group. He has participated in several multicenter trials of telemedicine screening for ROP including the eROP trial. He has also published on basic mechanisms of neovascularization in ROP, and predictive models of ROP development.